Astria Therapeutics Current Assets

Astria Therapeutics (ATXS) currently reports a current assets of $250M as of September 2025. That compares with $350M in the prior-year period — down 27.9% year over year. Use the charts on this page to explore Astria Therapeutics's current assets history and peer comparisons.

Astria Therapeutics's current assets decreased from $350M to $250M — a 27.9% year-over-year decrease (period ending September 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Astria Therapeutics reported $250M in current assets as of September 2025. That compares with $350M in the prior-year period — down 27.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $250M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Astria Therapeutics, and consider following ATXS for alerts when major investors trade the stock.

Astria Therapeutics is classified in the Healthcare sector. On current assets, it currently shows $250M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ATXS with unrelated industries.